Battista Simone, Recenti Filippo, Kiadaliri Ali, Lohmander Stefan, Jönsson Thérése, Abbott Allan, Vinblad Johanna, Rolfson Ola, Englund Martin, Dell'Isola Andrea
School of Health and Society, Centre for Human Movement and Rehabilitation, University of Salford, Salford, UK.
Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Orthopaedics, Lund University, Lund, Sweden.
RMD Open. 2025 Feb 26;11(1):e005133. doi: 10.1136/rmdopen-2024-005133.
This study evaluated the effects of a 6-week osteoarthritis (OA) exercise and education intervention on metabolic health markers, including blood pressure (BP), glycated haemoglobin (HbA1c), high-density lipoprotein (HDL), cholesterol levels and weight in individuals with both OA and diabetes.
Data originated from the Swedish Osteoarthritis and Diabetes cohort, which is composed of the Swedish Osteoarthritis Register (SOAR) and National Diabetes Register. We included individuals diagnosed with OA and diabetes who underwent the intervention between January 2008 and December 2019, matched with controls with diabetes who did not based on birth year, sex, OA site (hip/knee) and OA diagnosis year. Outcomes included BP, HbA1c, HDL, total cholesterol levels and weight measured up to 3 years before and after SOAR enrolment. Statistical analyses used two-way fixed-effect models.
The study included 4571 individuals with OA and diabetes (mean age: 69.5, SD: 7.8; women: 52.7%; knee OA: 71.2%) and 7925 controls. The intervention group showed a systolic BP decrease of approximately 1.0 mm Hg at 6 and 12 months compared with the control group. HDL levels increased by about 0.02 mmol/L at 12, 18 and 24 months. Weight decreased by approximately 0.5 kg at 6, 18 and 30 months. HbA1c levels increased by approximately 0.5 mmol/mol at 6 months. No essential differences were found in the total cholesterol levels.
An OA exercise and education intervention designed following OA clinical practice guidelines led to small and unlikely clinically relevant improvements in metabolic health markers in individuals with OA and diabetes.
本研究评估了为期6周的骨关节炎(OA)运动与教育干预对患有OA和糖尿病的个体代谢健康指标的影响,这些指标包括血压(BP)、糖化血红蛋白(HbA1c)、高密度脂蛋白(HDL)、胆固醇水平和体重。
数据来源于瑞典骨关节炎与糖尿病队列,该队列由瑞典骨关节炎登记处(SOAR)和国家糖尿病登记处组成。我们纳入了2008年1月至2019年12月期间接受干预的被诊断为OA和糖尿病的个体,并根据出生年份、性别、OA部位(髋部/膝部)和OA诊断年份与未接受干预的糖尿病对照组进行匹配。观察指标包括在纳入SOAR之前和之后长达3年测量的BP、HbA1c、HDL、总胆固醇水平和体重。统计分析采用双向固定效应模型。
该研究纳入了4571例患有OA和糖尿病的个体(平均年龄:69.5岁,标准差:7.8;女性:52.7%;膝OA:71.2%)和7925例对照组。与对照组相比,干预组在6个月和12个月时收缩压下降了约1.0 mmHg。HDL水平在12个月、18个月和24个月时升高了约0.02 mmol/L。体重在6个月、18个月和30个月时下降了约0.5 kg。HbA1c水平在6个月时升高了约0.5 mmol/mol。总胆固醇水平未发现显著差异。
按照OA临床实践指南设计的OA运动与教育干预,使患有OA和糖尿病的个体代谢健康指标出现了微小且不太可能具有临床相关性的改善。